A cost analysis of a simplified model for HCV screening and treatment at a tertiary hospital in Zimbabwe.
Blessing DzingiraiLeolin KatsidziraVongai MwanesaniMaarten Jacobus PostmaMarinus van HulstNyashadzaishe MafirakurevaPublished in: Expert review of pharmacoeconomics & outcomes research (2024)
Screening and treatment of HCV-infected individuals using directly acting antivirals at a tertiary hospital in Zimbabwe may require substantial financial resources.